Management of the oral mucosal lesions seen in association with HIV infection.
Oral lesions cause considerable morbidity in association with HIV infection. Their successful management depends upon accurate diagnosis and the use of appropriate therapy. Various treatment approaches are described for some of the common oral lesions including Kaposi's sarcoma, oral candidiasis, hairy leukoplakia and recurrent oral ulcers associated with HIV disease. This paper will discuss the therapies available in the USA and UK. In other countries some of the drugs discussed will be available in different doses and preparations. In addition other drugs may be available in other parts of the world that are not licensed for use in the USA or UK, and their availability may vary.
Greenspan
D
D
Department of Stomatology, University of California San Francisco, CA, USA.
Shirlaw
P J
PJ
D000935:Antifungal Agents / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use*; D002180:Candidiasis, Oral / Q000188:drug therapy / Q000209:etiology; D017742:Dental Care for Chronically Ill / Q000379:methods*; D015658:HIV Infections / Q000150:complications*; D006566:Herpesviridae Infections / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D009059:Mouth Diseases / Q000209:etiology / Q000628:therapy*; D009061:Mouth Mucosa / Q000473:pathology*; D009062:Mouth Neoplasms / Q000209:etiology / Q000628:therapy*; D019226:Oral Ulcer / Q000188:drug therapy / Q000209:etiology
D000935:Antifungal Agents; D000998:Antiviral Agents